PLGA nanoparticles modified with a TNFα mimicking peptide, soluble Leishmania antigens and MPLA induce T cell priming in vitro via dendritic cell functional differentiation-Reference-Cited by-同舟云学术

PLGA nanoparticles modified with a TNFα mimicking peptide, soluble Leishmania antigens and MPLA induce T cell priming in vitro via dendritic cell functional differentiation

Published:2016-08 Issue: Volume:105 Page:18-31
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Margaroni Maritsa,Agallou Maria,Kontonikola Katerina,Karidi Konstantina,Kammona Olga,Kiparissides Costas,Gaitanaki Catherine,Karagouni Evdokia

Funder

NanoLeish

Greece and the European Regional Development Fund of the European Union

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference67 articles.

1. PLGA-based nanoparticles: an overview of biomedical applications;Danhier;J. Control. Release,2012

2. Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations;Hamdy;Adv. Drug Deliv. Rev.,2011

3. Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens;Jiang;Adv. Drug Deliv. Rev.,2005

4. Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma;Goforth;Cancer Immunol. Immunother.,2009

5. PLGA nanoparticle-mediated delivery of tumor antigenic peptides elicits effective immune responses;Ma;Int. J. Nanomed.,2012

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PLGA nanoparticle-delivered Leishmania antigen and TLR agonists as a therapeutic vaccine against cutaneous leishmaniasis in BALB/c mice;International Immunopharmacology;2024-09

2. CD4+ and CD8+ T-cell multi-epitope chimeric protein associated with an MPLA adjuvant induce protective efficacy and long-term immunological memory for the immunoprophylaxis of American Tegumentary Leishmaniasis;Vaccine;2024-08

3. Enhancing Control of Leishmania infantum Infection: A Multi-Epitope Nanovaccine for Durable T-Cell Immunity;Animals;2024-02-13

4. Immunomodulatory chitosan nanoparticles for Toxoplasma gondii infection: Novel application of chitosan in complex propranolol-hydrochloride as an adjuvant in vaccine delivery;International Journal of Biological Macromolecules;2023-12

5. Synthesis of L-Ornithine- and L-Glutamine-Linked PLGAs as Biodegradable Polymers;Polymers;2023-10-05